vancomycin has been researched along with sitafloxacin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, DT; Katz, L; Plattner, JJ | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Arai, T; Kinoshita, T; Nimura, N | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Biedenbach, DJ; Johnson, DM; Jones, RN; Marshall, SA | 1 |
| Chiba, M; Hiramatsu, K; Kurosaka, SM; Sato, K; Tanaka, M; Wada, N | 1 |
| Amemoto, Y; Aoyama, T; Arakawa, S; Deguchi, T; Egawa, S; Fujimoto, Y; Fujisawa, M; Goto, H; Hamasuna, R; Hanaki, H; Hashimura, T; Hayami, H; Hirose, T; Ichikawa, T; Inatomi, H; Ishihara, S; Ishikawa, K; Ishitoya, S; Ito, N; Ito, T; Iwata, S; Kadota, J; Kagara, I; Kaku, M; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Kobuke, M; Koda, S; Komeda, H; Kumon, H; Kunishima, Y; Maeda, H; Matsubara, A; Matsuda, Y; Matsui, T; Matsukawa, M; Matsumoto, M; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Muranaka, T; Nakamura, I; Nishimura, K; Oka, H; Okumura, K; Onishi, H; Onodera, S; Sato, J; Shigeta, M; Sunakawa, K; Taguchi, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Togo, Y; Tsugawa, M; Tsukamoto, T; Uehara, S; Wakeda, H; Watanabe, A; Yamada, D; Yamamoto, S; Yamashita, M; Yasuda, M | 1 |
| Bentley, KLM; Cherian, P; Ebetino, FH; Galloway, CA; Hofstee, MI; Liu, Y; Moriarty, TF; Neighbors, J; Rainbolt, J; Ren, Y; Schwarz, EM; Sun, S; Xie, C; Xue, T | 1 |
| Guo, S; Li, X; Li, Y; Shao, J; Tian, M; Tong, H; Wei, M; Xu, B; Yan, B | 1 |
| Cherian, P; de Mesy Bentley, KL; Ebetino, FH; Liu, Y; Masters, E; McKenna, CE; Neighbors, J; Rainbolt, J; Ren, Y; Schwarz, EM; Shu, Y; Sun, S; Weeks, J; Xie, C; Xue, T | 1 |
1 review(s) available for vancomycin and sitafloxacin
| Article | Year |
|---|---|
New directions in antibacterial research.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Molecular Sequence Data; Molecular Structure | 1996 |
11 other study(ies) available for vancomycin and sitafloxacin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Investigation of enantioselective separation of quinolonecarboxylic acids by capillary zone electrophoresis using vancomycin as a chiral selector.
Topics: Anti-Infective Agents; Electrophoresis, Capillary; Fluoroquinolones; Ofloxacin; Quinolones; Stereoisomerism; Vancomycin | 1996 |
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cell Division; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Quinolones; Streptococcus pneumoniae; Thienamycins; Time Factors; Vancomycin | 1996 |
Activity of two novel fluoroquinolones (DU-6859a and DV-7751a) tested against glycopeptide-resistant enterococcal isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; Vancomycin | 1995 |
In-vitro activity of DU-6859a against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibilities to vancomycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Humans; Methicillin Resistance; Sequence Analysis, DNA; Staphylococcus aureus; Vancomycin | 1998 |
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Topics: Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Japan; Klebsiella oxytoca; Klebsiella pneumoniae; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections; Vancomycin | 2015 |
Efficacy of Bisphosphonate-Conjugated Sitafloxacin in a Murine Model of
Topics: Animals; Anti-Bacterial Agents; Diphosphonates; Disease Models, Animal; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Mice; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution; Vancomycin | 2022 |
Sitafloxacin pharmacokinetics/pharmacodynamics against multidrug-resistant bacteria in a dynamic urinary tract infection in vitro model.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Escherichia coli; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections; Vancomycin | 2022 |
Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S. aureus infection with osseointegration in murine models of implant-associated osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Osseointegration; Osteomyelitis; Staphylococcal Infections; Vancomycin | 2023 |